| meta-analysis | Q815382 |
| review article | Q7318358 |
| scholarly article | Q13442814 |
| systematic review | Q1504425 |
| P819 | ADS bibcode | 2011PLoSO...629249B |
| P356 | DOI | 10.1371/JOURNAL.PONE.0029249 |
| P932 | PMC publication ID | 3245259 |
| P698 | PubMed publication ID | 22216224 |
| P5875 | ResearchGate publication ID | 51981616 |
| P50 | author | Bruce C. McKenzie | Q112510463 |
| Charles R Beck | Q121296086 | ||
| Rachel Isba | Q30508787 | ||
| Rebecca C. Harris | Q54080422 | ||
| Marko Kerac | Q56670683 | ||
| Felix Greaves | Q57936340 | ||
| Siobhan Farmer | Q58348285 | ||
| Elizabeth Orton | Q58348292 | ||
| Jonathan Nguyen Van-Tam | Q41448199 | ||
| P2093 | author name string | Jonathan Roberts | |
| Munib Haroon | |||
| Robert Howard | |||
| David A Ishola | |||
| Richard Puleston | |||
| Paul Fisher | |||
| Mary O'Brien | |||
| Yana Vinogradova | |||
| Sophie Kim | |||
| Girija Dabke | |||
| Hiroshi Horiuchi | |||
| Charlotte Stevenson | |||
| Neil Wigglesworth | |||
| Javier Peñalver | |||
| Dean Wallace | |||
| Lauren Ahyow | |||
| Joanne Enstone | |||
| Mitsuru Mukaigawara | |||
| Liz Lingard | |||
| Arina Zanuzdana | |||
| Gemma Morgan | |||
| Laura Béchard-Evans | |||
| Ahmed B Hashim | |||
| Caroline Hird | |||
| Gabriel Agboado | |||
| Glenda Augustine | |||
| Helene Denness | |||
| Jose Figureroa | |||
| Julia Rosser | |||
| Julie O'Boyle | |||
| Mobasher Butt | |||
| Rachel Weston | |||
| Sarah Theaker | |||
| Sophie Haroon | |||
| Vivienne Parish | |||
| P2860 | cites work | Influenza vaccination in children being treated with chemotherapy for cancer | Q24241660 |
| Safety of influenza vaccine in heart transplant recipients | Q77690404 | ||
| Restored humoral immune response to influenza vaccination in HIV-infected adults treated with highly active antiretroviral therapy | Q77719603 | ||
| A double-blind placebo-controlled study of the effect of influenza vaccination on airway responsiveness in asthma | Q77809596 | ||
| Response to influenza vaccine in children with leukemia undergoing chemotherapy | Q78760596 | ||
| Influenza vaccination as model for testing immune modulation induced by anti-TNF and methotrexate therapy in rheumatoid arthritis patients | Q79370395 | ||
| Risk factors for poor immune response to influenza vaccination in elderly people | Q79759122 | ||
| Immune responses following administration of influenza and pneumococcal vaccines to patients with rheumatoid arthritis receiving adalimumab | Q79784933 | ||
| Immunogenicity of influenza vaccination in patients with non-Hodgkin lymphoma | Q79898425 | ||
| Humoral response to hemagglutinin components of influenza vaccine in patients with non-Hodgkin malignant lymphoma | Q79997612 | ||
| Anti-tumor necrosis factor therapy does not diminish the immune response to influenza vaccine in Japanese patients with rheumatoid arthritis | Q80211460 | ||
| Immune response to influenza vaccine in pediatric patients with inflammatory bowel disease | Q80420684 | ||
| The effect of sirolimus therapy on vaccine responses in transplant recipients | Q80498988 | ||
| Immunogenicity and tolerability of a trivalent virosomal influenza vaccine in a cohort of HIV-infected children | Q80808207 | ||
| Influence of vaccination and surgery on HLA-DR expression in patients with upper aerodigestive tract cancer | Q80993821 | ||
| Lung transplant patients' T cell responses to influenza vaccine viruses between seasons | Q81106237 | ||
| Impact of influenza vaccine on response to vaccination with pneumococcal vaccine in HIV patients | Q81805131 | ||
| A/H1N1 influenza vaccination in patients with systemic lupus erythematosus: Safety and immunity | Q82459170 | ||
| Influenza vaccine after pediatric kidney transplant: a Midwest Pediatric Nephrology Consortium study | Q83011818 | ||
| Safety of live attenuated influenza vaccine in mild to moderately immunocompromised children with cancer | Q83876420 | ||
| Patients with humoral primary immunodeficiency do not develop protective anti-influenza antibody titers after vaccination with trivalent subunit influenza vaccine | Q84114360 | ||
| Humoral and cellular immune responses after influenza vaccination in kidney transplant recipients | Q84352036 | ||
| Influenza vaccine administration in rheumatoid arthritis patients under treatment with TNFalpha blockers: safety and immunogenicity | Q84760318 | ||
| H1N1 influenza vaccination and infection in pediatric heart transplants | Q84993378 | ||
| The immunosuppressive effects of long-term combination chemotherapy in children with acute leukemia in remission | Q93820571 | ||
| Influenza vaccination among heart transplant recipients | Q44880353 | ||
| Immunization with influenza vaccine in patients with haematological malignant disease | Q44951658 | ||
| Efficacy and immunologic responses to influenza vaccine in HIV-1-infected patients | Q45091241 | ||
| Impact of corticosteroids on the immune response to a MF59-adjuvanted influenza vaccine in elderly COPD-patients | Q45195784 | ||
| Antibody response to tetravalent influenza subunit vaccine in patients infected with human immunodeficiency virus type 1. | Q45393870 | ||
| Abnormal humoral immune response to influenza vaccination in pediatric type-1 human immunodeficiency virus infected patients receiving highly active antiretroviral therapy | Q45402246 | ||
| Influenza virus vaccination of patients with SLE: effects on generation of autoantibodies | Q45730988 | ||
| Cancer patients undergoing chemotherapy show adequate serological response to vaccinations against influenza virus and Streptococcus pneumoniae | Q45731339 | ||
| Safety, vaccine virus shedding and immunogenicity of trivalent, cold-adapted, live attenuated influenza vaccine administered to human immunodeficiency virus-infected and noninfected children | Q45734511 | ||
| Influenza virus vaccination and booster in B-cell chronic lymphocytic leukaemia patients | Q45735659 | ||
| Influenza vaccination of human immunodeficiency virus 1-infected patients receiving antiretroviral therapy | Q45737045 | ||
| Influenza A among patients with human immunodeficiency virus: an outbreak of infection at a residential facility in New York City | Q45737300 | ||
| Influenza virus-stimulated generation of anti-human immunodeficiency virus (HIV) activity after influenza vaccination in HIV-infected individuals and healthy control subjects | Q45738342 | ||
| Influenza virus immunization effectivity in kidney transplant patients subjected to two different triple-drug therapy immunosuppression protocols: mycophenolate versus azathioprine | Q45744019 | ||
| Comparison of the safety, vaccine virus shedding, and immunogenicity of influenza virus vaccine, trivalent, types A and B, live cold-adapted, administered to human immunodeficiency virus (HIV)-infected and non-HIV-infected adults | Q45744556 | ||
| The effect of influenza vaccination on human immunodeficiency virus type 1 load: a randomized, double-blind, placebo-controlled study | Q45766090 | ||
| T cell activation and human immunodeficiency virus replication after influenza immunization of infected children. | Q45767495 | ||
| The immunogenicity of influenza virus vaccine in solid organ transplant recipients | Q45767721 | ||
| Antibody response of pediatric solid organ transplant recipients to immunization against influenza virus. | Q45772795 | ||
| Serologic response to standard inactivated influenza vaccine in human immunodeficiency virus-infected children. | Q45778593 | ||
| Influenza virus vaccine in B-cell chronic lymphocytic leukaemia patients | Q45780123 | ||
| Immunological response to influenza virus vaccine in B-cell chronic lymphocytic leukaemia patients | Q45786146 | ||
| Human immunodeficiency virus-type 1 replication can be increased in peripheral blood of seropositive patients after influenza vaccination. | Q45787891 | ||
| Antibody responses to immunization of patients with hemophilia with and without evidence of human immunodeficiency virus (human T-lymphotropic virus type III) infection. | Q45830663 | ||
| The influence of human immunodeficiency virus (HIV) infection on antibody responses to influenza vaccines | Q45839260 | ||
| Responses of patients with neoplastic diseases to influenza virus vaccine | Q45889412 | ||
| Studies of cell-mediated immune responses to influenza vaccination in systemic lupus erythematosus. | Q45915270 | ||
| Attenuated antibody reaction for the primary antigen but not for the recall antigen of influenza vaccination in patients with non-Hodgkin B-cell lymphoma after the administration of rituximab-CHOP. | Q45993733 | ||
| Influenza vaccination of patients with systemic lupus erythematosus. | Q46202181 | ||
| Vaccination against influenza in patients with rheumatoid arthritis: the effect of rituximab on the humoral response | Q46559627 | ||
| Poor immunogenicity of the H1N1 2009 vaccine in well controlled HIV-infected individuals | Q46586099 | ||
| Influenza vaccination is efficacious and safe in renal transplant recipients | Q46830965 | ||
| Antibody response to influenza vaccination in splenectomized patients in Poland | Q47683746 | ||
| Effects of influenza vaccination in HIV-infected adults: a double-blind, placebo-controlled trial | Q47773594 | ||
| Immunization with both T cell-dependent and T cell-independent vaccines augments HIV viral load secondarily to stimulation of tumor necrosis factor alpha | Q47919875 | ||
| Effect of a second, booster, influenza vaccination on antibody responses in quiescent systemic lupus erythematosus: an open, prospective, controlled study | Q44197482 | ||
| Influenza immunisation in children with solid tumours | Q44222857 | ||
| Reactogenicity and Immunogenicity of Bivalent Influenza A and Monovalent Influenza B Virus Vaccines in High-Risk Children | Q44255997 | ||
| Influenza vaccine administration in patients with systemic lupus erythematosus and rheumatoid arthritis. Safety and immunogenicity. | Q44263536 | ||
| The efficacy of influenza vaccination in a pediatric oncology population. | Q44436455 | ||
| Influenza vaccination in HIV-infected children | Q44463632 | ||
| Humoral responses after influenza vaccination are severely reduced in patients with rheumatoid arthritis treated with rituximab | Q44477199 | ||
| Antibody response to influenza immunization in patients with systemic lupus erythematosus. | Q44607894 | ||
| Antibody response to influenza vaccination in renal transplant patients: correlation with allograft function | Q44710200 | ||
| Influenza vaccination does not promote cellular or humoral activation among heart transplant recipients | Q44873229 | ||
| The feasibility of creating a checklist for the assessment of the methodological quality both of randomised and non-randomised studies of health care interventions | Q27860564 | ||
| Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement | Q27860868 | ||
| Mortality associated with influenza and respiratory syncytial virus in the United States | Q29615578 | ||
| Influenza-associated hospitalizations in the United States | Q29619463 | ||
| Influenza A/pandemic 2009/H1N1 in the setting of allogeneic hematopoietic cell transplantation: a potentially catastrophic problem in a vulnerable population | Q30227384 | ||
| Efficacy and clinical effectiveness of influenza vaccines in HIV-infected individuals: a meta-analysis. | Q30356791 | ||
| A nosocomial outbreak of 2009 pandemic influenza A(H1N1) in a paediatric oncology ward in Italy, October-November 2009. | Q30384305 | ||
| Incidence of 2009 pandemic influenza A H1N1 infection in England: a cross-sectional serological study. | Q30384762 | ||
| Preliminary Estimates of Mortality and Years of Life Lost Associated with the 2009 A/H1N1 Pandemic in the US and Comparison with Past Influenza Seasons | Q30387439 | ||
| Pandemic Influenza A (H1N1) 2009 and mortality in the United Kingdom: risk factors for death, April 2009 to March 2010. | Q30389702 | ||
| Low rate of seroconversion after vaccination with a split virion, adjuvanted pandemic H1N1 influenza vaccine in HIV-1-infected patients | Q30390471 | ||
| Prolonged viral shedding in pandemic influenza A(H1N1): clinical significance and viral load analysis in hospitalized patients | Q30394867 | ||
| Seroprotective titers against 2009 H1N1 influenza A virus after vaccination in allogeneic hematopoietic stem cell transplantation recipients. | Q30394925 | ||
| Maraviroc does not affect humoral response to the pandemic influenza A-H1N1v 2009 adjuvanted vaccine in HIV-1-infected patients | Q30395098 | ||
| Repeated vaccination is required to optimize seroprotection against H1N1 in the immunocompromised host | Q30395200 | ||
| Immunogenicity of pandemic (H1N1) 2009 vaccine in children with cancer in the United Kingdom | Q30396068 | ||
| Hospitalization in two waves of pandemic influenza A(H1N1) in England | Q30396701 | ||
| Mortality of 2009 pandemic influenza A(H1N1) in Germany. | Q30397533 | ||
| Early post-transplant vaccination with pandemic influenza A/H1N1 vaccine in pediatric heart transplant recipients | Q30397755 | ||
| Immunogenicity and tolerability of an inactivated and adjuvanted pandemic H1N1 influenza vaccine, in HIV-1-infected patients | Q30397897 | ||
| Antibody response after a single dose of an AS03-adjuvanted split-virion influenza A (H1N1) vaccine in heart transplant recipients | Q30400225 | ||
| Clinical features and outcome of 2009-influenza A (H1N1) after allogeneic hematopoietic SCT. | Q30400983 | ||
| Nosocomial pandemic (H1N1) 2009, United Kingdom, 2009-2010 | Q30401581 | ||
| The effect of anti-tumour necrosis factor alpha treatment on the antibody response to influenza vaccination | Q33845366 | ||
| Effect of annual influenza immunization on antibody response in lung transplant patients | Q33859908 | ||
| A prospective, comparative study of the immune response to inactivated influenza vaccine in pediatric liver transplant recipients and their healthy siblings | Q33908062 | ||
| Comparison of neutralizing and hemagglutination-inhibiting antibody responses to influenza A virus vaccination of human immunodeficiency virus-infected individuals | Q33993586 | ||
| Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2010 | Q34129986 | ||
| Efficacy of the influenza vaccine in patients with malignant lymphoma | Q34146495 | ||
| Impaired serum antibody response to inactivated influenza A and B vaccine in renal transplant recipients | Q34408545 | ||
| Influenza vaccination and chemotherapy: a shot in the dark? | Q34918081 | ||
| Response to influenza immunisation during treatment for cancer | Q35270361 | ||
| Vaccination against influenza in rheumatoid arthritis: the effect of disease modifying drugs, including TNF alpha blockers | Q35636798 | ||
| Influenza vaccination in kidney transplant recipients: cellular and humoral immune responses | Q50590166 | ||
| Serum antibody response to influenza vaccine in pulmonary patients receiving corticosteroids | Q50613600 | ||
| Antibody response after influenza vaccination in HIV-infected individuals: a consecutive 3-year study. | Q50660364 | ||
| Immune response to influenza vaccination in children and adults with asthma: effect of corticosteroid therapy. | Q50743271 | ||
| Influenza immunization of adult patients with malignant diseases | Q50948355 | ||
| Anti-influenza vaccination in systemic lupus erythematosus patients: an analysis of specific humoral response and vaccination safety. | Q51887243 | ||
| Compromised B cell responses to influenza vaccination in HIV-infected individuals. | Q51993087 | ||
| Immune response after influenza vaccination in children with cancer. | Q53666988 | ||
| Influenza vaccination on renal transplant patients is safe and serologically effective. | Q54441113 | ||
| Influenza vaccination in heart transplant recipients. | Q54721560 | ||
| Safety and efficacy of two types of influenza vaccination in heart transplant recipients: a prospective randomised controlled study | Q57000068 | ||
| Outbreak of novel influenza A (H1N1) in an adult haematology department and haematopoietic cell transplantation unit: clinical presentation and outcome | Q57098094 | ||
| Pandemic influenza vaccine in adult HIV-1-infected patients | Q57107097 | ||
| Humoral and Cellular Response to Influenza Vaccine in HIV-Infected Children With Full Viroimmunologic Response to Antiretroviral Therapy | Q57451098 | ||
| Immunologic and virologic evaluation after influenza vaccination of HIV-1-infected patients | Q57766305 | ||
| Immunization of patients with rheumatoid arthritis against influenza: a study of vaccine safety and immunogenicity | Q57769585 | ||
| Antibody Responses After Influenza and Pneumococcal Immunization in HIV-Infected Homosexual Men | Q58737468 | ||
| Antibody responses after influenza and pneumococcal immunization in HIV-infected homosexual men | Q58737476 | ||
| Evaluation of Immune Responses to Seasonal Influenza Vaccination in Healthy Volunteers and in Patients After Stem Cell Transplantation | Q58789095 | ||
| Immunogenicity of influenza vaccine (1993–1994 winter season) in HIV-seropositive and -seronegative ex-intravenous drug users | Q58864140 | ||
| Activation of virus replication after vaccination of HIV-1-infected individuals. | Q36365672 | ||
| Safety and immunogenicity of two influenza virus subunit vaccines, with or without MF59 adjuvant, administered to human immunodeficiency virus type 1-seropositive and -seronegative adults | Q36452409 | ||
| Seroconversion after influenza vaccination in patients with lung cancer | Q36620042 | ||
| Immunogenicity of vaccination against influenza, Streptococcus pneumoniae and Haemophilus influenzae type B in patients with multiple myeloma | Q36641621 | ||
| Effects of influenza immunization on humoral and cellular alloreactivity in humans | Q36661931 | ||
| Duration of influenza A virus shedding in hospitalized patients and implications for infection control | Q36969238 | ||
| Efficacy of influenza vaccination in HIV-positive patients: a systematic review and meta-analysis | Q37058557 | ||
| Oseltamivir-resistant influenza virus A (H1N1), Europe, 2007-08 season | Q37164761 | ||
| Immune response to influenza vaccine in children with inflammatory bowel disease | Q37247576 | ||
| Influenza in immunosuppressed populations: a review of infection frequency, morbidity, mortality, and vaccine responses | Q37416103 | ||
| Influenza vaccination in liver transplant recipients | Q38925889 | ||
| Clinical and serological responses to an inactivated influenza vaccine in adults with HIV infection, diabetes, obstructive airways disease, elderly adults and healthy volunteers | Q38976668 | ||
| Antibody response to influenza immunization in kidney transplant recipients receiving either azathioprine or mycophenolate: a controlled trial. | Q39129794 | ||
| Randomised placebo-controlled crossover trial on effect of inactivated influenza vaccine on pulmonary function in asthma. | Q39303371 | ||
| Antibody response after influenza immunization in renal transplant patients receiving cyclosporin A or azathioprine | Q40184313 | ||
| Adverse reactions of trivalent influenza vaccine in HIV-infected individuals | Q40341441 | ||
| Influenza vaccine antibody responses in lung transplant recipients. | Q40452512 | ||
| Influenza vaccination in orthotopic liver transplant recipients: absence of post administration ALT elevation | Q40523980 | ||
| Antibody Responses to Influenza Immunization of Children with Acute Lymphoblastic Leukemia | Q40619886 | ||
| Influenza vaccination of children during acute asthma exacerbation and concurrent prednisone therapy | Q40665952 | ||
| Clinical and Antibody Responses After Influenza Immunization in Systemic Lupus Erythematosus | Q40681905 | ||
| Influenza immunization in children with chronic arthritis: a prospective study | Q40712710 | ||
| Humoral and cell mediated immune response to bivalent influenza A/NJ/76 and A/Vict/75 vaccine in renal allograft recipients | Q40857845 | ||
| Influenza Vaccination in Renal Transplant Recipients | Q40859972 | ||
| Influenza immunization of children with neoplastic diseases | Q40862981 | ||
| Response to Influenza A Vaccine Among High-Risk Patients | Q40985257 | ||
| Efficacy of influenza vaccination in HIV-infected persons. A randomized, double-blind, placebo-controlled trial | Q41692217 | ||
| Effect of influenza vaccination on viral replication and immune response in persons infected with human immunodeficiency virus receiving potent antiretroviral therapy | Q41718835 | ||
| Poor serological responses upon influenza vaccination in patients with rheumatoid arthritis treated with rituximab | Q42340004 | ||
| Immunization against influenza during the 2005/2006 epidemic season and the humoral response in children with diagnosed inflammatory bowel disease (IBD). | Q42922963 | ||
| Impaired serum antibody response to inactivated influenza A and B vaccine in cancer patients | Q42927446 | ||
| Response to influenza immunisation in asymptomatic HIV infected men. | Q42949054 | ||
| Safety of concomitant administration of seasonal and/or H1N1 flu vaccination in patients receiving erlotinib for advanced non-small cell lung cancer | Q43084809 | ||
| Response to influenza virus vaccination in vertical HIV infection | Q43103500 | ||
| Immunogenicity of trivalent influenza vaccine in children with acute lymphoblastic leukemia during maintenance therapy | Q43174307 | ||
| Influenza virus vaccination in kidney transplant recipients: serum antibody response to different immunosuppressive drugs | Q43275816 | ||
| Influenza vaccination of human immunodeficiency virus (HIV)-infected adults: impact on plasma levels of HIV type 1 RNA and determinants of antibody response | Q43459414 | ||
| Assessment of the immune response to trivalent split influenza vaccine in children with solid tumors | Q43604166 | ||
| Effect of influenza virus vaccine on the expression of human immunodeficiency virus co-receptor CCR5. | Q43789818 | ||
| Viral loads and duration of viral shedding in adult patients hospitalized with influenza. | Q43873120 | ||
| The humoral immune response to influenza vaccination in lung transplant patients | Q43877540 | ||
| Influenza immunization in immunosuppressed children | Q43898292 | ||
| The uptake of influenza and pneumococcal vaccination among immunocompromised patients attending rheumatology outpatient clinics | Q43916953 | ||
| Immunogenicity and effect of a virosomal influenza vaccine on viral replication and T-cell activation in HIV-infected children receiving highly active antiretroviral therapy | Q43939498 | ||
| Dynamics of HIV-1 replication following influenza vaccination of HIV+ individuals | Q44089095 | ||
| Impact of influenza-like illness and effectiveness of influenza vaccination in oncohematological children who have completed cancer therapy | Q59396766 | ||
| HIV-1 plasma viremia not increased in patients receiving highly active antiretroviral therapy after influenza vaccination | Q59680254 | ||
| Influenza vaccination of HIV-1-positive and hiv-1-negative former intravenous drug users | Q60264582 | ||
| Serological response to influenza vaccine after hematopoetic stem cell transplantation | Q61771597 | ||
| Humoral and Cellular Responses to Influenza Vaccination in Human Recipients Naturally Tolerant to a Kidney Allograft | Q63880654 | ||
| Humoral immune response after vaccination against influenza in patients with breast cancer. | Q64896210 | ||
| Antibody response to influenza immunization in adult patients with malignant disease | Q66956827 | ||
| Bivalent Influenza Vaccine in Children with Cancer | Q67063882 | ||
| Influenza vaccination of patients with systemic lupus erythematosus | Q67349586 | ||
| The influence of chemotherapy on response of patients with hematologic malignancies to influenza vaccine | Q67467316 | ||
| Impairment of the immune response to influenza vaccination in renal transplant recipients by cyclosporine, but not azathioprine | Q68905280 | ||
| Response to Influenza Vaccine by Renal Transplant Patients | Q69355610 | ||
| The influence of HIV infection on antibody responses to a two-dose regimen of influenza vaccine | Q69741135 | ||
| Influenza vaccination in dialysis and transplant patients | Q69924655 | ||
| Immunization against influenza in children with cancer: results of a three-dose trial | Q70266495 | ||
| Antibody response to a two-dose regimen of influenza vaccine in allogeneic T cell-depleted and autologous BMT recipients | Q70557635 | ||
| Immune response to influenza vaccination in children with renal disease | Q70947378 | ||
| Trial of split-product trivalent influenza vaccine in high-risk children | Q71451667 | ||
| Vaccination against influenza in pulmonary tuberculosis patients | Q71519276 | ||
| [Influenza vaccination of patients with pulmonary tuberculosis in the tuberculosis dispensary] | Q71716465 | ||
| Effective immunization against influenza in pediatric renal transplant recipients | Q71976882 | ||
| Humoral response to influenza hemagglutinin: oligoclonal spectrotype and failure of thymopentin as immunoadjuvant | Q72210321 | ||
| Influenza immunization of HIV-1-infected patients does not increase HIV-1 viral load | Q72402717 | ||
| Antibody response to influenza, tetanus and pneumococcal vaccines in HIV-seropositive individuals in relation to the number of CD4+ lymphocytes | Q72681854 | ||
| Antibody response to a two-dose influenza vaccine regimen in adult lymphoma patients on chemotherapy | Q72770789 | ||
| Influenza vaccine in chronic lymphoproliferative disorders and multiple myeloma | Q73172466 | ||
| The comparison of antibody response to influenza vaccination in continuous ambulatory peritoneal dialysis, hemodialysis and renal transplantation patients | Q73390945 | ||
| Efficacy of influenza vaccination in adult liver transplant recipients | Q73616901 | ||
| Immune response to influenza vaccine in adult liver transplant recipients | Q73753116 | ||
| Antibody response to influenza immunization in patients after heart transplantation | Q73788338 | ||
| Study on efficacy of influenza vaccination in renal allograft recipients | Q74094194 | ||
| Immunogenicity of subunit trivalent influenza vaccine in children with acute lymphoblastic leukemia | Q74287647 | ||
| Immunogenicity and safety of a virosomal influenza vaccine in HIV-infected children | Q74289720 | ||
| Immunogenicity of influenza vaccine in patients with hemato-oncological disorders | Q74484107 | ||
| Influenza vaccination in children with chronic rheumatic diseases and long-term immunosuppressive therapy | Q74576917 | ||
| Immune responses to influenza immunization in children receiving maintenance chemotherapy for acute lymphoblastic leukemia | Q75369403 | ||
| The response in hemagglutinoinhibiting antibodies following influenza vaccination of HIV-infected children | Q77324702 | ||
| Antibody responses to vaccinations given within the first two years after transplant are similar between autologous peripheral blood stem cell and bone marrow transplant recipients | Q77462756 | ||
| Differential immune response to influenza and pneumococcal vaccination in immunosuppressed patients after heart transplantation | Q77658512 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 12 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | public health | Q189603 |
| influenza vaccine | Q383260 | ||
| systematic review | Q1504425 | ||
| health policy | Q1519812 | ||
| P304 | page(s) | e29249 | |
| P577 | publication date | 2011-12-22 | |
| P1433 | published in | PLOS One | Q564954 |
| P1476 | title | Influenza vaccination for immunocompromised patients: systematic review and meta-analysis from a public health policy perspective | |
| P478 | volume | 6 |
| Q50033604 | Acetylcholine Receptor Antibody Titers and Clinical Course after Influenza Vaccination in Patients with Myasthenia Gravis: A Double-Blind Randomized Controlled Trial (ProPATIent-Trial). |
| Q89134564 | Altered immune cell follicular dynamics in HIV infection following influenza vaccination |
| Q91614864 | Alternative-Dose versus Standard-Dose Trivalent Influenza Vaccines for Immunocompromised Patients: A Meta-Analysis of Randomised Control Trials |
| Q30430658 | Does vaccine dose predict response to the monovalent pandemic H1N1 influenza a vaccine in children with acute lymphoblastic leukemia? A single-centre study. |
| Q28067038 | Effectiveness of MF59-adjuvanted seasonal influenza vaccine in the elderly: A systematic review and meta-analysis |
| Q28081489 | Healthcare workers' willingness to work during an influenza pandemic: a systematic review and meta-analysis |
| Q38284708 | Immunogenicity against Far Eastern and Siberian subtypes of tick-borne encephalitis (TBE) virus elicited by the currently available vaccines based on the European subtype: systematic review and meta-analysis |
| Q36384717 | Immunogenicity and acceptance of influenza A (H1N1) vaccine in a cohort of chronic hepatitis C patients receiving pegylated-interferon treatment |
| Q35807191 | Immunogenicity and safety of intradermal influenza vaccine in immunocompromized patients: a meta-analysis of randomized controlled trials |
| Q37484576 | Immunogenicity of influenza vaccine in colorectal cancer patients |
| Q43161977 | Immunogenicity of trivalent influenza vaccine in patients with lung cancer undergoing anticancer chemotherapy |
| Q33892358 | Impaired B cell immunity in acute myeloid leukemia patients after chemotherapy. |
| Q37714705 | Infection risk in rheumatoid arthritis and spondyloarthropathy patients under treatment with DMARDs, corticosteroids and TNF-α antagonists |
| Q34370991 | Influenza vaccination for immunocompromised patients: summary of a systematic review and meta-analysis. |
| Q26829551 | Influenza vaccination for immunocompromised patients: systematic review and meta-analysis by etiology |
| Q27007483 | Influenza vaccination in HIV-positive subjects: latest evidence and future perspective |
| Q47612308 | Influenza vaccination status and outcomes among influenza-associated hospitalizations in Columbus, Ohio (2012-2015). |
| Q47137946 | Influenza vaccine effectiveness against influenza-related hospitalization during a season with mixed outbreaks of four influenza viruses: a test-negative case-control study in adults in Canada |
| Q92050198 | Mapping Host-Related Correlates of Influenza Vaccine-Induced Immune Response: An Umbrella Review of the Available Systematic Reviews and Meta-Analyses |
| Q38186856 | Methodological quality of systematic reviews on influenza vaccination |
| Q38125555 | Microbes and allogeneic transplantation. |
| Q36971789 | Prevention of infection caused by immunosuppressive drugs in gastroenterology. |
| Q27324763 | Protective immunity and safety of a genetically modified influenza virus vaccine |
| Q30210481 | Safety and immunogenicity of a vero cell culture-derived whole-virus H5N1 influenza vaccine in chronically ill and immunocompromised patients |
| Q27001157 | The effectiveness of convalescent plasma and hyperimmune immunoglobulin for the treatment of severe acute respiratory infections of viral etiology: a systematic review and exploratory meta-analysis |
| Q39429254 | Theoretical Basis of the Test-Negative Study Design for Assessment of Influenza Vaccine Effectiveness |
| Q26796420 | Vaccination in patients with primary immune deficiency, secondary immune deficiency and autoimmunity with immune regulatory abnormalities |
Search more.